Report Description

India gentamycin market is expected to grow at a formidable rate during the forecast period. The India gentamycin market is driven by the growing prevalence of animal diseases outbreaks. Gentamycin finds maximum usage in veterinary medicine. Additionally, gentamycin is used in the treatment of several human diseases and infections including urinary tract infections, renal disorders, sepsis, among others. This in turn is expected to positively influence the market growth during the forecast period. Besides, the high efficacy and affordability of the medication are further expected to fuel the market growth through FY2026. 

The India gentamycin market is segmented based on source, form, route of administration, distribution channel, application, company and region. Based on route of administration, the market can be categorized into eye drops, tablet, capsule, syrup, injection, cream, gel, ointment and others. The intravenous route is expected to witness significant growth in the market through FY2026 since a large dose of drug can be administered using this route of drug administration. Also, this is the most effective route of administration for the drugs that are not orally absorbed with 100% bioavailability.

The major players operating in the India gentamycin market are Taj Pharmaceuticals Ltd., Bayer India Ltd., Zydus Cadila Healthcare Ltd., Neon Laboratories Ltd., Hetero Healthcare Ltd., Gracure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Fresenius Kabi India Pvt. Ltd., Nestor Pharmaceuticals Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India gentamycin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India gentamycin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India gentamycin market based on source, form, route of administration, distribution channel, application, company and regional distribution.
  • To identify dominant region or segment in the India gentamycin market.
  • To identify drivers and challenges for India gentamycin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India gentamycin market.
  • To identify and analyze the profile of leading players operating in India gentamycin market.
  • To identify key sustainable strategies adopted by market players in India gentamycin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India gentamycin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Gentamycin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to gentamycin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India gentamycin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Gentamycin Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Gentamycin Market, By Form:
    • Eye Drops
    • Tablet
    • Capsule
    • Syrup
    • Injection
    • Cream
    • Gel
    • Ointment
    • Others
  • India Gentamycin Market, By Route of Administration:
    • Ophthalmic
    • Intravenous
    • Topical
    • Oral
    • Others
  • India Gentamycin Market, By Distribution Channel:
    • Online
    • Offline
  • India Gentamycin Market, By Application:
    • Bacterial Infection
    • Urinary Tract Infection
    • Sepsis
    • Meningitis
    • Skin or Soft Tissue Infection
    • Upper Respiratory Tract Infection
    • Others
  • India Gentamycin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India gentamycin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Gentamycin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Gentamycin Market

4.    Executive Summary

5.    Manufacturing Gentamycin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Gentamycin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Gentamycin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Eye Drops, Tablet, Capsule, Syrup, Injection, Cream, Gel, Ointment, Others)

7.2.3.     By Route of Administration (Ophthalmic, Intravenous, Topical, Oral, Others)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Bacterial Infection, Urinary Tract Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory Tract Infection, Others)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Taj Pharmaceuticals Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Bayer India Ltd.

14.1.3.  Zydus Cadila Healthcare Ltd.

14.1.4.  Neon Laboratories Ltd.

14.1.5.  Hetero Healthcare Ltd.

14.1.6.  Gracure Pharmaceuticals Ltd.

14.1.7.  Intas Pharmaceuticals Ltd.

14.1.8.  Alembic Pharmaceuticals Ltd.

14.1.9.  Fresenius Kabi India Pvt. Ltd.

14.1.10.                Nestor Pharmaceuticals Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

Gentamycin Market to grow at a formidable rate Until FY2026

Oct, 2020

Growing prevalence of bacterial infections is expected to drive the growth of India gentamycin market.